Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-26-003670
Filing Date
2026-04-21
Accepted
2026-04-20 18:23:25
Documents
51
Period of Report
2026-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q blackhawk_10q.htm   iXBRL 10-Q 479842
2 EXHIBIT 31.1 blackhawk_ex31-1.htm EX-31.1 14907
3 EXHIBIT 31.2 blackhawk_ex31-2.htm EX-31.2 14973
4 EXHIBIT 32.1 blackhawk_ex32-1.htm EX-32.1 6049
5 EXHIBIT 32.2 blackhawk_ex32-2.htm EX-32.2 6001
  Complete submission text file 0001829126-26-003670.txt   3160312

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bkhau-20260228.xsd EX-101.SCH 30023
7 XBRL CALCULATION FILE bkhau-20260228_cal.xml EX-101.CAL 28535
8 XBRL DEFINITION FILE bkhau-20260228_def.xml EX-101.DEF 132448
9 XBRL LABEL FILE bkhau-20260228_lab.xml EX-101.LAB 232939
10 XBRL PRESENTATION FILE bkhau-20260228_pre.xml EX-101.PRE 210079
54 EXTRACTED XBRL INSTANCE DOCUMENT blackhawk_10q_htm.xml XML 343147
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-41984 | Film No.: 26876348
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)